NFIL3 contributes to cytotoxic T lymphocyte-mediated killing
Open Biology · 2024
DOI: 10.1098/rsob.230456 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Biology, 2024. Verfasst von Tiphaine Douanne und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cambridge Institute for Medical Research, Keith Peters Building, Cambridge CB2 0XY, UK. Hauptthemen laut MEDLINE: T-Lymphocytes, Cytotoxic, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Bettencourt Schueller Foundation.
Abstract (Originalsprache)
Cytotoxic T lymphocytes (CTLs) are key effectors of the adaptive immune system that recognize and eliminate virally infected and cancerous cells. In naive CD8 + T cells, T-cell receptor (TCR) engagement drives a number of transcriptional, translational and proliferation changes over the course of hours and days leading to differentiation into CTLs. To gain a better insight into this mechanism, we compared the transcriptional profiles of naive CD8 + T cells to those of activated CTLs. To find new regulators of CTL function, we performed a selective clustered regularly interspaced short palindromic repeats (CRISPR) screen on upregulated genes and identified nuclear factor IL-3 (NFIL3) as a potential regulator of cytotoxicity. Although NFIL3 has established roles in several immune cells including natural killer, Treg, dendritic and CD4 + T cells, its function in CD8 + CTLs is less well understood. Using CRISPR/Cas9 editing, we found that removing NFIL3 in CTLs resulted in a marked decrease in cytotoxicity. We found that in CTLs lacking NFIL3 TCR-induced extracellular signal-regulated kinase phosphorylation, immune synapse formation and granule release were all intact while cytotoxicity was functionally impaired in vitro . Strikingly, NFIL3 controls the production of cytolytic proteins as well as effector cytokines. Thus, NFIL3 plays a cell intrinsic role in modulating cytolytic mechanisms in CTLs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cambridge Institute for Medical Research, Keith Peters Building, Cambridge CB2 0XY, UK.
- Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
ORCID-Profile: Tiphaine Douanne, Adam M Rochussen, Gillian M Griffiths
Förderung
- Wellcome Trust
- Bettencourt Schueller Foundation
Zitieren
APA
Douanne, T., Strege, K., Del Castillo Velasco-Herrera, M., Rochussen, A. M., Adams, D. J., & Griffiths, G. M. (2024). NFIL3 contributes to cytotoxic T lymphocyte-mediated killing. Open Biology. https://doi.org/10.1098/rsob.230456
Vancouver
Douanne T, Strege K, Del Castillo Velasco-Herrera M, Rochussen AM, Adams DJ, Griffiths GM. NFIL3 contributes to cytotoxic T lymphocyte-mediated killing. Open Biology. 2024. doi:10.1098/rsob.230456
BibTeX
@article{Douanne2024,
author = {Douanne, Tiphaine and Strege, Katharina and Del Castillo Velasco-Herrera, Martin and Rochussen, Adam M and Adams, David J and Griffiths, Gillian M},
title = {NFIL3 contributes to cytotoxic T lymphocyte-mediated killing},
journal = {Open Biology},
year = {2024},
doi = {10.1098/rsob.230456}
}
EUVIMED